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Abstract Nearly 40 % of pregnant women are infected with
Toxoplasma gondii. Primary infections in pregnant women
result, in approximately 30–50 % of patients, in transmission
of T. gondii through the placenta to the fetus and then in
congenital infections with severe, sometimes fatal course.
Studies still do not provide sufficient data on the genetic bases
of the immunity in fetuses, newborns, and infants with con-
genital toxoplasmosis. Previous research showed the contri-
bution of toll-like receptors (TLRs) to non-specific immunity
against T. gondii invasion, observed in T. gondii-infected
animals, especially mice. So far, the activity of TLRs in
defense against T. gondii infections was observed particularly
for TLR2, TLR4, and TLR9 molecules. Differential TLR
activity associates with both cell types, including a variety of
placental cells and stage of pregnancy. Several single-
nucleotide polymorphisms (SNPs) residing in three genes
encoding these receptors were reported as significant genetic
modifications of TLRs associated with different pregnancy
disorders. Despite those data, genetic alterations of TLRs
which have contributed to innate immune response against
T. gondii infections are still not precisely described. In this
article, we present reasons for the research of the plausible role
of SNPs residing in TLR2, TLR4, and TLR9 genes in congen-
ital toxoplasmosis development.
TLRs contribute to Toxoplasma gondii infections
Toxoplasmosis is one of the most frequent pregnancy infec-
tions transmitted from mother to child and the major cause
of perinatal morbidity and mortality [1–3]. In Poland, nearly
40 % of pregnant women are infected with Toxoplasma
gondii [4, 5]. Meiosis occurred in oocysts of T. gondii and
resulted in the production of many different genotypes of
parasitic sporozoites; however, three predominant distinct
clonal lines (virulent strain I and non-virulent strains II and
III) were found in Europe and North America [1, 6, 7].
Primary infections are dangerous in pregnant women, occur-
ring usually asymptomatically, resulting, in approximately
30–50 % of patients, in transmission of T. gondii through the
placenta to the fetus. As a result, these infections cause, in
the fetuses and newborns, with immature immune systems,
congenital infections with very severe, sometimes fatal
course [3, 5, 8]. So far, extensive investigations aimed to
describe mechanisms of congenital infections and related
immune responses. However, current studies do not provide
sufficient data on the associated alterations and genetic
background of the innate immunity to T. gondii occurring
in newborns and infants congenitally infected with this
parasite. Three of ten human toll-like receptors (TLRs),
TLR2, TLR4, and TLR9, have been reported to play roles
in the recognition of T. gondii, course of infections with this
parasite, and also in pregnancy progression and disorders.
So far, studies clearly confirmed the essential role of
TLR/MyD88 signaling in non-specific antimicrobial im-
mune response to T. gondii infections. Many previous works
reported the crucial role of IL-12 and of IFN-γ, the major
regulators of IFN-γ production, by NK and T cells and cell-
mediated immunity to T. gondii, respectively ([9, 10],
reviewed in [11, 12]). The high expression levels of these
two cytokines are stimulated after primary infection with T.
gondii [11]. In mice, TLR11 was reported as the main
regulator of IL-12 production following T. gondii infection
([11, 13], reviewed in [14]). However, TLR11 in humans is
only a non-functional pseudogene [11, 15]. Hence, in this
study, we described the role of other receptors from the TLR
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family in the defense against T. gondii. We suppose that
genetic modifications, especially of TLR2, TLR4, and TLR9,
might play a plausible role in congenital toxoplasmosis
development. To argue the major role of TLRs in innate
immune response to T. gondii, we described the most recent
studies showing their involvement in immunity to this par-
asite. Figure 1 illustrates the activities and interactions of
TLRs and other molecules reported to be involved in the
immune response to T. gondii infection.
The latest study performed to describe the method of
action of lipoxin- and L-kynurenine-induced SOCS2 in the
pro-inflammatory response during infection also with T.
gondii showed the engagement of both mediators in the
inhibition of TLR/MyD88, TLR/TRIF, IL-1R/MyD88, and
CD40/CD154 signaling pathways [16] (Fig. 1). Other stud-
ies reported that TLR response to T. gondii is promoted by
the ζ isoform of the diacylglycerol (DAG) kinases family
(DGKζ), expressed in macrophages (MΦ) and dendritic
cells (DC) via a pathway involving the inhibition of PI3K
[17] (Fig. 1). DGKζ deficiency resulted in impaired IL12
and TNF-α production after in vitro and in vivo TLR
stimulation, elevated resistance to endotoxin shock, and
increased susceptibility to T. gondii infection [17]. Studies
which aimed to describe the role of DC in the immune
response to T. gondii showed that mice with targeted inac-
tivation of MyD88 in these cells, but not in macrophages or
neutrophils, were highly susceptible to the T. gondii infec-
tion [18]. Subsequent results indicated the crucial role of
TLR recognition by DC in the creation of a rapid type 1
innate immunity to T. gondii and to prevent acute mortality
[18]. Murine CD11c+Gr-1+ DC infected with T. gondii, in
contrast with non-infected cells, had no ability for ex vivo
TLR stimulation [19]. Then, the observed results suggested
that plasmacytoid DCs (pDCs) were utilized by T. gondii as
Trojan horses in the early infection, with suppressed cyto-
kine effector function, and exploited to disseminate the
parasite within the host [19]. Earlier studies also reported
the important cell-intrinsic role of MyD88 in the activation
of neutrophils, macrophages, DC, and T cells during immu-
nity to T. gondii [11, 12]. However, the function of MyD88
in neutrophils, macrophages, and monocytes has to be de-
termined in detail. MyD88−/− mice orally infected with T.
gondii failed to control the parasite and succumbed within
2 weeks of infection, but the i.p. vaccinations of these mice
with avirulent T. gondii uracil auxotroph induced strong IFN
responses and protective immunity to the invasion of high-
virulence T. gondii strains [20]. Hence, the results of this
study confirmed that MyD88 is required to control T. gondii
infection, but the adaptive immunity might be induced with-
out the involvement of TLR adaptor molecule [20].
As MyD88 might be activated by almost all TLRs except
TLR3, recent investigations also aimed to identify particular
receptors crucial for the initial recognition of T. gondii. One
of the latest studies showed that single nucleotide-sensing
TLR3, TLR7, and TLR9 have no function in controlling the
initial activation of innate immune response and host resis-
tance to T. gondii infection in the 3d mice with a non-
functional UNC93B1, a critical mediator of the transloca-
tion of the three investigated TLRs from ER to endolyso-
somes [21] (Fig. 1). However, 3d mice were extremely
susceptible to infection with T. gondii. Therefore, the likely
combined action of nucleotide-sensing TLR3, TLR7, and
TLR9 in host defense against T. gondii was suggested [21].
Studies of 264 healthy Russian Karelian children per-
formed to analyze the influence of the gene environment
effect of T. gondii, Helicobacter pylori, CD14 −159C>T,
and TLR4 +1896A>G polymorphisms on the total serum
IgE showed no association between T. gondii or H. pylori
seropositivity, or CD14 and TLR4 polymorphisms with
IgE levels [22]. However, the constructed multiway analy-
sis of variance (ANOVA) model showed the influence of
CD14 −159 allele T and H. pylori antibodies status on the
serum total IgE [22].
The role of TLR2, TLR4, and TLR9 in Toxoplasma
gondii infections
Among TLR characteristics for human cells, the activity in
sensing T. gondiiwas especially determined for TLR2, TLR4,
and TLR9 molecules [23–26]. In the transcriptome-profiling
study performed to identify genes synergistically up-regulated
by IFN-γ and TNF in macrophages, several proinflammatory
cytokines and also TLR agonists were reported to stimulate
increased expression of newly identified immunoresponsive
gene 1 (IRG1) transcript [27]. The expression of IRG1 tran-
script was up-regulated after the stimulation of TLR2, TLR4,
and TLR9 by LTA, lipopolysaccharide (LPS), and CpG, re-
spectively. As IRG1 expression was not regulated by TLR3
stimulated by poly I:C, which is not signaled via MyD88, the
molecule involved in the signaling of TLR2, TLR4, and
TLR9, the MyD88 molecule, was suggested to be required
for the induction of IRG1 [27] (Fig. 1). In other work, TLR2-
deficient mice infected with 300 cysts of T. gondii died within
a period of 10 days; however, all of them survived when the
parasite dose was lower [28]. In T. gondii infection cases,
TLR2 participated in macrophages activation and regulation
of parasite-induced NO production [28]. Another study
showed that iNOS−/− mice were able to control the acute T.
gondii infection, in which additional effector mechanisms
were possibly regulated by TLR2 [29]. This receptor was also
reported to regulate the T. gondii-induced production of the
neutrophil-attracting chemokine CCL2 [30]. Experiments
with the vaccination of T. gondii-infected mice with T. gon-
dii-derived heat shock protein 70 (T.g.HSP70) gene showed its
involvement in DC activation and Th1 polarization observed
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at draining lymph nodes (dLN) from wild type and TLR2-
deficient mice, but not TLR4-deficient individuals with B6
background [31]. Early Th1 polarization was induced at the
dLN of mice by the T.g.HSP70 gene vaccine through the
TLR4/MyD88 signal pathway (Fig. 1). At an acute phase of
toxoplasmosis, the T.g.HSP70 gene vaccine also limited the
copy number of T. gondii in the mesenteric LN of WT, TLR2-
deficient, and TRIF-deficient mice, but for neither TLR4-
deficient nor MyD88-deficient mice, indicating the involve-
ment of TLR4 in the vaccine effect at an acute phase of
infection. What is more, TLR4 had activity in the determina-
tion of the T. gondii cyst number of the brain at a chronic phase
of toxoplasmosis, observed also at 8 and 12 weeks post-
infection [31]. TLR4-mediated macrophage activation was
observed during T. gondii and Leishmania donovani infection,
although this response was differentially regulated by proges-
terone via the glucocorticoid and progesterone receptors [23].
Another study showed that purified T. gondii glycosylphos-
phatidylinositols (GPI) triggered TLR4 signaling pathways as
well [24]. Mice lacking both TLR2 and TLR4, but not TLR2
alone, had completely abrogated production of TNF in the
response of T. gondii GPI [24]. However, mice deficient in
TLR4 were only a little more susceptible to the T. gondii
infection [24]. A significant role of TLR4 was reported in T.
Fig. 1 Toll-like receptor (TLR) signaling pathways involved in immune response to Toxoplasma gondii infections. Molecules considered to be
crucial during T. gondii infection are underlined and surrounded by a thick continuous line
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gondii infection observed in the small intestine [32]. TLR9-
deficient mice infected orally with T. gondii were relatively
resistant to the ileitis and had reduced Th1 response to the
parasite [25, 26]. TLR9 deficiency in mice infected orally with
T. gondii resulted in increased susceptibility to the infection
and a 50 % reduction in IFN-γ production [26]. Then, the
results proved that the TLR9 contribution coordinated both
innate and adaptive immune response to T. gondii. However,
the crucial indirect role in the stimulation of immunity to T.
gondii is possibly characteristic for commensal gut bacteria
rather than the parasite itself [25, 33].
The activity of TLRs during pregnancy
The expression of TLR genes was observed in immune and
also in non-immune cells such as trophoblasts, decidual
cells, and amniotic epithelium [34–36]. The expression pro-
file of TLR was associated with cell types, stage of pregnan-
cy, and response to microorganisms ([34, 36–38], reviewed
in [39, 40]). Studies performed for paraffin-embedded sec-
tions of endometrium and deciduas from first and second
trimester elective terminations and third trimester normal
deliveries showed alterations in the TLR4 expression levels
between particular tissue samples [34]. Higher immunore-
activity of TLR4 observed in decidual cells compared to
interstitial trophoblasts suggested maternally derived cells
as the main protectors against Gram-negative bacteria and
other harmful signals from severe inflammation associated
with or without infection. Particularly, significantly higher
TLR4 levels were observed in decidual cells of the first and
third trimester compared to second trimester basalis, sug-
gesting that an enhanced inflammatory environment oc-
curred at the maternal–fetal interface in the initial stages
and end of pregnancy compared to mid-pregnancy [34]. In
turn, another study showed the presence of TLR2 and TLR4
proteins expressions from the one-cell stage through the
blastocyst stage during murine embryo development [41].
In trophoblast stem cells, the expression of TLR2 and TLR6
but not TLR1 or TLR4 was observed [41]. At the plasma
membrane, the expression of only TLR2 molecules was
determined. The limited expression of TLRs on trophoblast
cells suggested that early trophoblasts might be less able to
protect embryos against pathogenic agents compared to
differentiated trophoblast cells [41]. The obtained results
are consistent with outcomes of another study, which indi-
cated that TLR4 expression and related IL-8 secretion that
occurred after LPS stimulation might be assigned, rather, to
leukocytes, as it was no longer observed in trophoblast
fraction purified from leukocytes [42]. The expression of
different antimicrobial peptides and proteins was suggested
to be characteristic for various placental cells and resulted
from the cooperation between leukocytes and cells of
embryonic origin [42]. Functional screening tests of TLRs
in human amniotic epithelial cells showed that the expres-
sion of TLR5, TLR6/2, and TLR4 occurred in these cells
[35]. The activation of TLR5 and TLR6/2 stimulated both
IL-6 and IL-8 production and the NF-κB signaling pathway,
whereas TLR4 activity was associated with reduced viabil-
ity of analyzed cells and their apoptosis. Hence, differential
immune response mediated via specific TLRs might even
lead to preterm birth [35]. Other data suggested a contribu-
tion of TLR ligands to the direct activation of decidual NK
cells and also NK cell lines observed in the presence of
proinflammatory cytokines [43]. In human decidual mono-
nuclear cells (DMNC), LPS, known as the TLR4 ligand,
induced IFN-γ and TNF-α production, from which the
former was IL-2- and IL-12-dependent, while the latter
was independent [43]. Hence, further studies were sug-
gested to be necessary to determine the mechanisms driving
the synergistic effect of TLR and cytokine signaling [43].
Research of cultured cells of term placenta, including
cytotrophoblast- and syncytiotrophoblast-rich cells, showed
the expression of TLR2, TLR3, TLR4, TLR5, TLR6, and
TLR9 genes [36]. In first-trimester primary trophoblasts
and trophoblast cell lines, the expression of TLR1, TLR2,
TLR3, and TLR4, but not TLR6, was observed [37, 44].
However, the last gene was expressed in third-trimester
trophoblasts, which suggested its regulation in a temporal
manner [36, 37]. The TLR4 expression level was higher in
the term compared to the first-trimester placentas [45].
Placentas from early pregnancy were reported as being less
responsive to pathogen agents than term tissues. TLR2 and
TLR4 transcripts were identified in villous cytotrophoblast
and extravillous trophoblast, but not in syncytiotrophoblasts
in the first-trimester placenta [37]. It also suggested the
regulation of TLR in a spatial manner. Then, it seemed that
pathogens might be dangerous to the fetus only when the
TLR-negative outer trophoblast layer is interrupted and
infecting agents enter either the placental villous or the
decidual compartments [37, 44]. The level of TLR1–
TLR10 transcripts was also investigated in term human
placentas collected in the absence of labor (elective cesarean
sections; ECS) and after the completion of labor (normal
vaginal delivery; NVD) [38]. TLR1–TLR10 transcripts
were observed in all placentas; however, NVD tissues pro-
duced higher levels of TNFA in response to TLR4 (LPS)
and to TLR7/8 agonist (resiquimod) than ECS placenta
explants. Significantly elevated levels of TLR2 and TLR5
correlated with labor. Hence, this data suggested the role of
TLR in parturition [38]. Studies of mRNA expressions of
TLR2, TLR3, TLR4, and TLR9 in the uterus, cervix, and
placenta of non-pregnant and across gestation CD-1 mice
showed significantly elevated levels in pregnant uterine and
cervical tissues [46]. The differential levels of TLR mRNA
expressions were observed between the uterus, cervix, and
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placenta with significantly down-regulated TLR4 gene ex-
pression in the placenta [46]. The data suggested that the
innate immune system was an active and dynamic system
during gestation, with the altered expression of TLRs at the
maternal–fetal interface playing a crucial role in the patho-
genesis of adverse pregnancy outcomes.
Despite data confirming the involvement of TLR2,
TLR4, and TLR9 receptors in the non-specific immunity
to T. gondii, their contribution to toxoplasmosis develop-
ment, and function within pregnancy, detailed mechanisms
driving the activity of these receptors in T. gondii congenital
infections are not known. So far, previous research showed
the participation of several single-nucleotide polymor-
phisms (SNPs) of TLR2, TLR4, and TLR9 in various dis-
eases and pregnancy disorders [47–49].
SNPs in the TLR2 gene associated with pregnancy
disorders
In a group of 200 cord blood samples obtained from 72 atopic
and 128 non-atopic mothers, 12 SNPs located in TLR1, TLR2,
TLR4, TLR6, and TLR10 were genotyped to describe their
possible influence on T-regulatory cells required for keeping
immune responses in balance and roles played in atopic dis-
eases [50]. In neonates, the presence of AA genotype of the
TLR2 promoter rs4696480 SNP associated with the increased
expression of FOXP3 and Treg marker genes GITR and
LAG3, and also the secretion of TH2 cytokines and TNF-α
in case of maternal atopy, with Tregs diminished without
maternal atopy. The occurrence of GG genotype of TLR2
rs1898830 correlated with Treg marker genes decreasing with
and increasing without maternal atopy [50]. The screening of
common TLR2 (2258 G>A) and co-segregating TLR4
(1063A>G and 1363C>T) SNPs in 94 women with pre-
eclampsia and 176 healthy pregnancy controls showed the
associations of these SNPs with early-onset but not late-
onset preeclampsia [47]. Then, three TLR SNPs lowering
thresholds for early-onset and severe pregnancy disease, but
not late-onset or mild pregnancy disease, was described [47].
In turn, a study of 288 vaginal samples obtained from 144
women during both the first and second trimesters of preg-
nancy performed to determine the correlation of 34 SNPs
residing in nine genes involved in TLR-mediated and -
related sensing and regulation of pathogens with the vaginal
carriage of Gram-positive anaerobes Gardnerella vaginalis
and Atopobium vaginae showed no association between gene
polymorphisms and bacterial vaginosis (BV) [51]. No signif-
icant correlation was determined for TLR2 −15607A>G,
1350T>C, 2258G>A, and 2029C>T SNPs [51]. The lack of
a relationship between TLR2 polymorphisms and BV occur-
rence is consistent with the results of another study, performed
to determine the influence of four TLR2 SNPs [rs18988
(−15607 A>G), rs4696483, rs7656411, and rs1337)] on the
cervical levels of pro- and anti-inflammatory cytokines and
their association with BV [52]. In another study, analyses of
the relevance of polymorphisms located in genes associated
with innate immunity performed for a large cohort of preterm
very-low-birth and term-born infants and their mothers
showed no significant correlation between the presence of
TLR2 2258G>A SNP and the occurrence of intrauterine infec-
tions as the cause of preterm birth [53]. Another study also
showed that comparable frequencies of the mutated 2258G
allele of the TLR2 gene occurred in both pregnant womenwith
preterm labor and healthy individuals [54]. In turn, another
investigation reported that infants with two polymorphic
TLR2 alleles (−16934TA/AA and 2258GA/AA) had, impor-
tantly, shorter gestational ages [55].
SNPs in the TLR4 gene associated with pregnancy
disorders
For the TLR4 gene, 1063A>G and 1363C>T SNPs were the
most commonly studied. Real-time polymerase chain reaction
(PCR) assays followed by high resolution melt (HRM) anal-
ysis, performed to simultaneously identify SNPs from TLR4
(1063A>G) as well as other genes IL6, IL1β, and IL12RB
involved in the immune response showed no association of
these polymorphisms with preterm birth of infants in
Montevideo, Uruguay [48]. However, in the same population,
fetuses carrying the 1063A>G SNP were both severely pre-
mature and had premature rupture of membranes (PROM) at
the same time [56]. In a Canadian cohort which included
mainly preterm infants, this TLR4 SNP occurred at a signifi-
cantly lower frequency in infants without bronchopulmonary
dysplasia (BPD) compared to those with diagnosed BPD.
However, no significant association was observed between
TLR4 genotypes and prematurity [57]. In turn, the research
of a Finnish population showed the presence of the 1063A>G
SNP in both infants and mothers and its correlation with
preterm labor [58]. The frequency of TLR4 1063A/G alleles
and their association with preterm labor might be population-
specific. It seems that further determination of the contribution
of the 1063A>G SNP to preterm labor is required. In contrast
to TLR2 polymorphisms, two SNPs located in the TLR4 se-
quence (rs1554973 or rs7856729) interacted significantly with
IL-1R2 rs485127 and correlated with the concentration of IL-
1β in 188 African American and European American women
[59]. The study showed both TLR4 and IL1-R2 genotypes as
possible significant markers of cervical cytokines IL-1α or IL-
1β concentrations and involvement in disparity in pregnancy
outcomes. However, the observed associations were no longer
significant after correction for multiple testing in European or
African Americans [59]. An earlier study reported a genetic
association between TLR4 rs1554973 and the level of cervical
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cytokine IL-1β characteristic for European but not African
Americans, which was more significant in women with BV
compared to those without BV [52]. These results are consis-
tent with the observation that selection on TLRs varies be-
tween human populations [60]. In another study, the carriage
of TLR4 rs1554973 SNP strongly associated with chorionic
plate inflammation both in mothers and their singleton fetuses
[61]. Four SNPs of TLR4 [1063A>G (rs4986790), 1363C>T
(rs4986791), rs6478317, rs10759932] were reported to affect
T-cell regulation [50]. Two common 1063A>G (rs4986790)
and 1363C>T TLR4 SNPs correlated with increased IL-13
secretion in core blood mononuclear cells (CBMC) obtained
from umbilical veins after delivery and stimulated with
Dermatophagoides pteronyssinus. CBMC with TLR4
rs6478317 (GG) had higher IL-12 secretion observed after
stimulation with lipid A (LpA). 1063A>G (rs4986790) and
1363C>T TLR4 SNPs were associated with a higher risk for
atopic dermatitis [50]. Similarly to TLR2 SNPs, no TLR4
polymorphisms (rs1927914, 1063A>G, 1363C>T) were asso-
ciated with BV in 288 vaginal samples obtained from 144
women during both the first and second trimesters of pregnan-
cy [51]. However, another study showed that the 1063A>G
SNP, disturbing response to LPS, was correlated with an
increase in the vaginal pH and levels ofGardnerella vaginalis
and anaerobic Gram-negative bacteria [62]. In a study of the
occurrence of the 1363C>T SNP in pregnant women with
preterm labor and a control group, a lower frequency of
heterozygous CT genotype and mutated T allele was observed
in the study group [54]. Hence, this SNP might play a protec-
tive role against PROM in pregnant women. However, the
proposed hypothesis has to be further investigated in a larger
group of patients with PROM [54]. In Plasmodium falcipa-
rum-infected primiparous Ghanaian women, the 1063A>G
SNP elevated the risk of low birth weight in term infants 6-
fold and the risk of maternal anemia 5-fold [63]. The obtained
results suggested a correlation of the 1063A>G SNP with a
clinical picture of malaria during pregnancy. However, this
mutation did not associate with preterm labor [63], whereas
the 1363C>T SNP was, importantly, less common in women
with BV compared with individuals without BV [64].
SNPs in the TLR9 gene associated with diseases
and ocular toxoplasmosis
The accumulated data argued also for the association of
different TLR9 SNPs with a variety of disorders, along with
toxoplasmic retinochoroiditis, cervical cancer, mother-to-
child transmission (MTCT) of human immunodeficiency
virus type 1 (HIV-1), increased risk of low birth weight in
infants, risk of maternal anemia, and a clinical picture of
malaria in pregnancy [49, 63, 65, 66]. The 1635A>G SNP
residing in the TLR9 gene was reported to correlate with
toxoplasmic retinochoroiditis in Brazil [49]. In the studied
population, ocular toxoplasmosis was associated with allele
C at 1635A>G [odds ratio (OR) 7; 95 % confidence interval
(CI) 1.6–30.8), which was at a frequency of 0.424 %, similar
to that observed in European populations. The determined
correlation suggested that direct interaction between T. gon-
dii and TLR9 might trigger proinflammatory responses and,
hence, led to severe pathologies such as ocular disease,
associated with this infection in Brazil [49]. A study per-
formed for the Polish population showed the association of
TLR9 1635A>G and also rs187084 polymorphisms with
cervical cancer and the possible significance of these SNPs
as risk factors of cervical cancer development [65]. In turn,
another work showed the role of the c.4-44G>A and
c.1635A>G SNPs in MTCT of HIV-1 [66]. While neither
of the two SNPs were associated with a risk of HIV-1
infection, the [G;G] haplotype correlated with a higher risk
of MTCT of HIV-1 after adjustment for maternal viral
load [66]. A study performed for P. falciparum-infected
primiparous Ghanaian women reported a correlation of
the −1486T>C SNP residing in the TLR9 gene, just as in
the case of the 1063A>G SNP in the TLR4 gene, with an
elevated risk of low birth weight in term infants and the
risk of maternal anemia and, therefore, with a clinical
picture of malaria in pregnancy [63].
Concluding remarks
It is important to investigate molecular mechanisms in-
volved in Toxoplasma gondii congenital infections more
precisely. It seems necessary to identify, in clinical speci-
mens such as blood, amniotic fluid, cerebrospinal fluid, and
the placenta, the genetic alterations of TLR2, TLR4, and
TLR9 genes accompanying the development of these infec-
tions and to describe the clinical significance of single-
nucleotide polymorphisms (SNPs) residing in these genes
in regard to congenital toxoplasmosis. TLR genes were
suggested to play roles in toxoplasmosis development, pro-
gression of pregnancy, and various disorders of gestation.
One possible modification influencing gene function, which
was also confirmed in case of TLR2, TLR4, and TLR9 genes
in accordance to different diseases and pregnancy disorders,
is the occurrence of SNPs within the genetic sequence.
Therefore, the detailed description of the occurrence and the
role of SNPs located in these three genes of the TLR family
might pose a significant direction of research to determine
new genetic alterations involved in immunity against T. gondii
infections in pregnant women, their fetuses, and newborns.
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